Cargando…

Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein

OBJECTIVES: To identify the epitope on α-synuclein (α-syn) to which antibodies against the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) bind and to determine whether antibodies targeting this mimicry domain are present in human sera. METHODS: Reactivity of the α-syn-cross-reacting anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woulfe, John, Gray, Madison T., Ganesh, Munisha S., Middeldorp, Jaap M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864620/ https://www.ncbi.nlm.nih.gov/pubmed/27218119 http://dx.doi.org/10.1212/NXI.0000000000000239

Ejemplares similares

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas
por: Khabir, Abdelmajid, et al.
Publicado: (2005)

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
por: Keryer-Bibens, Cécile, et al.
Publicado: (2006)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity
por: Ysselstein, Daniel, et al.
Publicado: (2017)

An antibody scanning method for the detection of α-synuclein oligomers in the serum of Parkinson's disease patients
por: Kulenkampff, Klara, et al.
Publicado: (2022)

Specific Human Astrocyte Subtype Revealed by Affinity Purified GFAP(+1) Antibody; Unpurified Serum Cross-Reacts with Neurofilament-L in Alzheimer
por: Middeldorp, Jinte, et al.
Publicado: (2009)

EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules
por: Liu, Yue, et al.
Publicado: (2023)

Modification of Cɛ mRNA Expression by EBV-Encoded Latent Membrane Protein 1
por: Hanashiro, Kazuhiko, et al.
Publicado: (2006)

Binding Stability of Antibody—α-Synuclein Complexes Predicts the Protective Efficacy of Anti-α-synuclein Antibodies
por: Höllerhage, Matthias, et al.
Publicado: (2022)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

Antibodies against H1N1 influenza virus cross‐react with α‐cells of pancreatic islets
por: Qi, Zongli, et al.
Publicado: (2017)

EBV-IgA antibody responses in endemic and nonendemic populations with nasopharyngeal carcinoma: tumour marker prognostication study and a cross-sectional study
por: Budiningsih, Insani, et al.
Publicado: (2023)

Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection
por: Lam, Janice K. P., et al.
Publicado: (2018)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
por: Ahmed, Naveed, et al.
Publicado: (2022)

Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation
por: Scheibe, Christian, et al.
Publicado: (2021)

Cooperativity of α-Synuclein Binding to Lipid Membranes
por: Makasewicz, Katarzyna, et al.
Publicado: (2021)

Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.
por: Lando, P., et al.
Publicado: (1981)

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration
por: Endo, Kazuhira, et al.
Publicado: (2009)

Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies
por: Mao, Yuan, et al.
Publicado: (2013)

Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis
por: Ikeda, Masato, et al.
Publicado: (2022)

Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies
por: Zhang, Chaoting, et al.
Publicado: (2021)

α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
por: Guo, Qingyun, et al.
Publicado: (2023)

React and React Native
por: Boduch, Adam
Publicado: (2017)

React and React Native
por: Boduch, Adam
Publicado: (2020)

A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
por: Qiu, Jin, et al.
Publicado: (2011)

Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A
por: Liu, Xishuang, et al.
Publicado: (2011)

Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2)
por: Xue, Xiangyang, et al.
Publicado: (2011)

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells
por: Rancan, Chiara, et al.
Publicado: (2015)

A Monoclonal Antibody against p53 Cross-Reacts with Processing Bodies
por: Thomas, María Gabriela, et al.
Publicado: (2012)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
por: van Rooijen, Bart D., et al.
Publicado: (2010)

Membrane Lipid Co-Aggregation with α-Synuclein Fibrils
por: Hellstrand, Erik, et al.
Publicado: (2013)

Structural and Dynamical Insights into the Membrane-Bound α-Synuclein
por: Jain, Neha, et al.
Publicado: (2013)

Plasticity of Membrane Binding by the Central Region of α-Synuclein
por: Navarro-Paya, Carlos, et al.
Publicado: (2022)

Spermidine protects against α-synuclein neurotoxicity
por: Büttner, Sabrina, et al.
Publicado: (2014)

Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity
por: Gupta, Vijay, et al.
Publicado: (2020)

Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
por: Fołtyn, Sylwia, et al.
Publicado: (2017)

EBV Latent Membrane Protein 1 Activates Akt, NFκB, and Stat3 in B Cell Lymphomas
por: Shair, Kathy H. Y, et al.
Publicado: (2007)

EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity
por: Zhu, Nannan, et al.
Publicado: (2021)

Unexpected Instability of Family of Repeats (FR), the Critical cis-Acting Sequence Required for EBV Latent Infection, in EBV-BAC Systems
por: Kanda, Teru, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mrgkti73v3nqj93n8mihfbp0be